Kelly Joan L, Blomquist Preston H
Department of Ophthalmology, University of Texas Southwestern Medical Center at Dallas, TX 75390-9057, USA.
Tex Med. 2002 Apr;98(4):56-61.
To determine the usual approach to management of traumatic hyphema in Texas, we mailed a survey to ophthalmologists in the state who indicated a practice focus of either general ophthalmology or pediatric ophthalmology. The survey included inquiries regarding type of practice, patient population, frequency of traumatic hyphema, laboratory investigations, treatment precautions, medical and surgical treatment, criteria for hospitalization, and criteria for surgical intervention. Of the 495 surveys mailed out, 169 (response rate = 34.1%) were returned and filled out completely. More than half of the respondents do not routinely consider sickle cell testing in traumatic hyphema cases. We found no consensus regarding use of systemic antifibrinolytic agents, indications for hospitalization, or timing of surgical intervention. The results of this survey emphasize the lack of consensus surrounding treatment of traumatic hyphema. The relative paucity of sickle cell testing among Texas ophthalmologists, however, appears inconsistent with recommendations in the medical literature.
为确定德克萨斯州外伤性前房积血的常规管理方法，我们向该州表示专注于普通眼科或小儿眼科的眼科医生邮寄了一份调查问卷。该调查包括有关执业类型、患者群体、外伤性前房积血的发生频率、实验室检查、治疗注意事项、药物和手术治疗、住院标准以及手术干预标准的询问。在寄出的495份调查问卷中，169份（回复率 = 34.1%）被完整退回并填写。超过一半的受访者在处理外伤性前房积血病例时，通常不考虑进行镰状细胞检测。我们发现，在全身抗纤溶药物的使用、住院指征或手术干预时机方面，未达成共识。本次调查结果强调了在外伤性前房积血治疗方面缺乏共识。然而，德克萨斯州眼科医生中镰状细胞检测相对较少，这似乎与医学文献中的建议不一致。
